{
    "code": "56034652",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56034652",
    "time": "2023-01-27 06:37:17",
    "許可證字號": "衛部醫器輸字第034652號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD7002",
    "有效日期": "115\/05\/13",
    "發證日期": "110\/05\/13",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05603465208",
    "中文品名": "“凱杰”PIK3CA擴增反應突變檢驗試劑組",
    "英文品名": "“QIAGEN” therascreen PIK3CA RGQ PCR Kit",
    "效能": "本產品是一項即時定性PCR測試，使用從福馬林固定石蠟包埋(Formalin-Fixed, Paraffin-Embedded, FFPE)乳房腫瘤組織萃取的基因體DNA (gDNA)，檢測磷脂酸肌醇3激酶催化子單元α(PIK3CA)基因中的11項突變(外顯子7：C420R；外顯子9：E542K、E545A、E545D[僅限1635G>T]、E545G、E545K、Q546E、Q546R；和外顯子20：H1047L、H1047R、H1047Y)。本產品可用作為伴隨診斷測試，以輔助臨床人員依據PIK3CA突變偵測結果，識別可能適合接受PIQRAY(alpelisib)治療的乳癌患者。FFPE組織試樣中的一項或更多PIK3CA突變產生本產品陽性測試結果的患者，符合接受PIQRAY(alpelisib)治療的資格。",
    "醫器規格": "873111，以下空白。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B4020分析特定試劑",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入 36GMP",
    "申請商名稱": "620118K794  凱杰生物科技有限公司",
    "申請商地址": "臺北市中正區羅斯福路2段100號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "MDE0446000  QIAGEN GMBH",
            "製造廠廠址": "QIAGEN STRASSE 1 40724 HILDEN, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560346520001-110-12-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56034652&Seq=001&Type=9"
        },
        {
            "title": "560346520002-110-12-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56034652&Seq=001&Type=8"
        }
    ]
}